Infant Health and Bilirubin Management

A condition where a baby's bilirubin levels are too high, leading to yellowing of the skin and eyes.

Acute bilirubin encephalopathy (ABE) is a serious complication of hyperbilirubinemia, affecting the brain. It can manifest as poor feeding, lethargy, and even seizures in severe cases.

A test to assess the severity of bilirubin toxicity, particularly in infants.

Phototherapy is a treatment for hyperbilirubinemia, using blue light to break down bilirubin. In intensive phototherapy, the baby is exposed to a higher intensity of blue light.

Exchange transfusion is a medical procedure where the infant's blood is replaced with donor blood. This is used in severe cases of hyperbilirubinemia.

A rare condition characterized by the absence or destruction of the extrahepatic biliary tree and intrahepatic biliary ducts, resulting in conjugated neonatal hyperbilirubinemia.

An inflammatory condition affecting the larynx, trachea, and bronchi, primarily caused by the parainfluenza virus. It presents with a characteristic barking cough, inspiratory stridor, hoarseness, and respiratory distress in children aged 6 months to 6 years.

A neurologic syndrome caused by bilirubin deposition in the basal ganglia and brainstem nuclei, primarily affecting newborns with high levels of unconjugated bilirubin (>20 mg/dL). It can lead to significant long-term morbidity and mortality.

Also known as rheumatic fever, is a multisystem inflammatory disease that occurs 2-4 weeks after a group A β-hemolytic streptococcal infection. It can affect the heart, joints, nervous system, and skin, resulting in complications like carditis, arthritis, Sydenham chorea, erythema marginatum, and subcutaneous nodules.

A severe and often fatal condition affecting newborns with high levels of unconjugated bilirubin. Unconjugated bilirubin crosses the blood-brain barrier, depositing in the basal ganglia and brainstem nuclei, leading to a wide range of neurologic impairments.